• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Join GSA in Boston for the nation’s premier aging conference!

Bioengineer by Bioengineer
October 18, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Gerontological Society of America (GSA) invites all journalists to attend its 2018 Annual Scientific Meeting — the country's largest interdisciplinary conference in the field of aging — from November 14 to 18 in Boston, Massachusetts. Media representatives intending to cover the meeting may register free of charge.

An estimated 4,000 professionals are expected to attend the five-day gathering at the John B. Hynes Veterans Memorial Convention Center, Sheraton Boston Hotel, and Marriott Boston Copley Place. The theme for 2018 is "The Purposes of Longer Lives" and the program schedule contains more than 500 scientific sessions featuring research presented for the first time. Noteworthy meeting highlights include:

  • A wealth of story ideas: GSA offers direct access to leading authorities and new discoveries in gerontology. Explore the latest developments related to innovative technologies, Social Security and retirement, long-term care, human longevity, the impact of the 2018 elections, and much more. Stay tuned for an announcement about the launch of a searchable online program of all meeting sessions.
  • Networking opportunities: The Press Room, which serves as a base of operations for reporters, provides a venue for discussion about emerging issues on the aging beat. There will be a reception for reporters the evening of Friday, November 16.
  • Keynote address: GSA will welcome author, historian, filmmaker, and gerontologist Thomas R. Cole, PhD, FGSA. His 1992 book "The Journey of Life: A Cultural History of Aging in America" was nominated for a Pulitzer Prize, and he has published many other books and articles on the history of aging and humanistic gerontology. He was the senior editor of "The Handbook of Humanities and Aging," "Voices and Visions: Toward a Critical Gerontology," and "What Does It Mean to Grow Old?"

###

The complimentary media registration allows access to all scientific sessions and the Exhibit Hall. Registration information is available at http://www.geron.org/press.

We look forward to seeing you in Boston!

The Gerontological Society of America (GSA) is the nation's oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging. The principal mission of the Society — and its 5,500+ members — is to advance the study of aging and disseminate information among scientists, decision makers, and the general public. GSA's structure also includes a policy institute, the National Academy on an Aging Society, and an educational branch, the Academy for Gerontology in Higher Education.

Media Contact

Todd Kluss
[email protected]
202-587-2839
@geronsociety

http://www.geron.org

https://www.geron.org/press-room/press-releases/2018-press-releases/922-join-gsa-in-boston-for-the-nation-s-premier-aging-conference

Share12Tweet8Share2ShareShareShare2

Related Posts

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.